Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of Inecalcitol in Imatinib-Treated Chronic Myeloid Leukemia
2014-004347-12Phase 2Terminated
- Sponsor
- Hybrigenics
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of inecalcitol in chronic myelogenous leukemia (CML), sponsored by Hybrigenics. Primary endpoint: Proportion of responders achieving MR4.5 within 12 months. Started Jun 2015; status: terminated.
02
Drugs
inecalcitol
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on 2014-004347-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004347-12.